OPIANT PHARMACEUTICALS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2023

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2023	—	2	1
2022	—	5	1
2021	—	4	1
2020	—	4	1
2019	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE KPM GROUP DC LLC	—	18

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	4
SENATE	4
Health & Human Services, Dept of (HHS)	2
Centers For Medicare and Medicaid Services (CMS)	1
Substance Abuse & Mental Health Services Administration (SAMHSA)	1
White House Office	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	5
Health Issues	Health Issues	2

OPIANT PHARMACEUTICALS — Lobbying Disclosure | Poliscope